OPUM Technologies Ltd.01.07.22
Medical device and AI company, OPUM and orthopedic bracing manufacturer Thuasne Group have signed a partnership on a digital solution for non-invasive non-pharmacological treatment of osteoarthritis (OA).
The partnership’s focus is to digitize musculoskeletal care by using objective data, determining the best treatment methods for OA to improve patient outcomes and reduce overall costs. The first product will integrate OPUM’s AI-enabled Digital Knee care platform with Thuasne’s Rebel Reliever OA knee brace. Together the technologies will deliver personalized exercise and behavioral therapies direct to the patient while allowing remote monitoring at scale so clinicians can manage more patients with a higher quality of personalized care.
“We are thrilled to announce this partnership with OPUM which will be harnessing the power of our flagship Rebel Reliever OA knee brace and our trusted Townsend Motion hinge. Combining emerging digital solutions with industry-leading technology is an exciting prospect and we look forward to the opportunities ahead,” said Matthieu Ducottet, innovation director for Thuasne Group.
The Digital Knee Rebel Reliever is currently deployed at the Shirley Ryan AbilityLab (a top-ranked rehabilitation hospital in the United States) and other selected providers across the United States.
“This partnership is a key part of our vision to deliver scalable personalized musculosketal care to positively impact the lives of patients around the world. Our solution spans the joint health continuum helping guide patients, and their providers, from initial onset through optimally prescribed interventions to reach their goals,” said OPUM CEO Prof. Andrew McDaid.
OPUM empowers patients, providers and payers to conquer musculosketal health by surfacing actionable insights that enable better decision making. OPUM’s AI-driven platform enables optimal care to be delivered in a scalable way by reducing prescription burden, allowing stretched clinicians to care for more patients with personalized care plans to achieve better outcomes and align with reimbursement. OPUM is a venture-backed medical device and AI company formed off the foundation of years of medical device research. OPUM was founded in 2016 and global sales of the Digital Knee commenced in September 2020.
Founded in 1847, Thuasne imagines, develops and manufactures medical devices allowing everyone to become actors in their own health. For six generations, the Group offers concrete, adapted and innovative health solutions in the fields of orthopedics, medical compression, home care, and sports medicine. With its 2,200 employees, the company generated a turnover of 211 million euros in 2020, of which 40 percent was international sales. The Group is now present in 85 countries, in particular through its 15 subsidiaries in Europe, the United States and Asia.
The partnership’s focus is to digitize musculoskeletal care by using objective data, determining the best treatment methods for OA to improve patient outcomes and reduce overall costs. The first product will integrate OPUM’s AI-enabled Digital Knee care platform with Thuasne’s Rebel Reliever OA knee brace. Together the technologies will deliver personalized exercise and behavioral therapies direct to the patient while allowing remote monitoring at scale so clinicians can manage more patients with a higher quality of personalized care.
“We are thrilled to announce this partnership with OPUM which will be harnessing the power of our flagship Rebel Reliever OA knee brace and our trusted Townsend Motion hinge. Combining emerging digital solutions with industry-leading technology is an exciting prospect and we look forward to the opportunities ahead,” said Matthieu Ducottet, innovation director for Thuasne Group.
The Digital Knee Rebel Reliever is currently deployed at the Shirley Ryan AbilityLab (a top-ranked rehabilitation hospital in the United States) and other selected providers across the United States.
“This partnership is a key part of our vision to deliver scalable personalized musculosketal care to positively impact the lives of patients around the world. Our solution spans the joint health continuum helping guide patients, and their providers, from initial onset through optimally prescribed interventions to reach their goals,” said OPUM CEO Prof. Andrew McDaid.
OPUM empowers patients, providers and payers to conquer musculosketal health by surfacing actionable insights that enable better decision making. OPUM’s AI-driven platform enables optimal care to be delivered in a scalable way by reducing prescription burden, allowing stretched clinicians to care for more patients with personalized care plans to achieve better outcomes and align with reimbursement. OPUM is a venture-backed medical device and AI company formed off the foundation of years of medical device research. OPUM was founded in 2016 and global sales of the Digital Knee commenced in September 2020.
Founded in 1847, Thuasne imagines, develops and manufactures medical devices allowing everyone to become actors in their own health. For six generations, the Group offers concrete, adapted and innovative health solutions in the fields of orthopedics, medical compression, home care, and sports medicine. With its 2,200 employees, the company generated a turnover of 211 million euros in 2020, of which 40 percent was international sales. The Group is now present in 85 countries, in particular through its 15 subsidiaries in Europe, the United States and Asia.